Outcomes
- 01
oncology-overall-response-rate-percent
3 evidence rows
- lim_2009_cohort_cytorreductive-therapy-in-108-adults-with-systemic-mastocytosis-outcome-analysis-and-response-prediction-during-treatment-with-interferon-alpha-hydroxyurea-imatinib-mesylate-or-2-chlorodeoxyadenosine
- pagano_2008_cohort_advanced-mast-cell-disease-an-italian-hematological-multicenter-experience
- vega-ruiz_2009_cohort_phase-ii-study-of-imatinib-mesylate-as-therapy-for-patients-with-systemic-mastocytosis